Sagent Pharmaceuticals, Inc. 4
4 · Sagent Pharmaceuticals, Inc. · Filed Aug 31, 2016
Insider Transaction Report
Form 4
Jonathon M Singer
Chief Financial Officer
Transactions
- Disposition from Tender
Common Stock
2016-08-29$21.75/sh−7,857$170,890→ 27,206 total - Disposition to Issuer
Common Stock
2016-08-29$21.75/sh−27,206$591,731→ 0 total - Disposition to Issuer
Common Stock
2016-08-29$21.75/sh−3,665$79,714→ 35,063 total - Disposition to Issuer
Stock Option to Buy
2016-08-29$7.14/sh−34,783$248,351→ 0 totalExercise: $14.61Exp: 2026-02-22→ Common Stock (34,783 underlying) - Disposition to Issuer
Stock Option to Buy
2016-08-29$1.59/sh−10,638$16,914→ 0 totalExercise: $20.16Exp: 2024-02-18→ Common Stock (10,638 underlying) - Disposition to Issuer
Stock Option to Buy
2016-08-29$1.65/sh−55,000$90,750→ 0 totalExercise: $20.10Exp: 2021-09-19→ Common Stock (55,000 underlying) - Disposition to Issuer
Stock Option to Buy
2016-08-29$5.30/sh−12,067$63,955→ 0 totalExercise: $16.45Exp: 2023-02-21→ Common Stock (12,067 underlying)
Footnotes (7)
- [F1]Pursuant to the Agreement and Plan of Merger by and among Nichi-Iko Pharmaceutical Co. Ltd., Shepard Vision, Inc. and Sagent Pharmaceuticals, Inc. (the "Merger Agreement"), these shares were canceled and converted into the right to receive $21.75 per share in cash, without interest, less any applicable withholding taxes (the "Consideration").
- [F2]Pursuant to the Merger Agreement, these shares were disposed of in a cash tender offer by Shepard Vision, Inc. to acquire common stock of Sagent Pharmaceuticals, Inc. in exchange for the Consideration.
- [F3]Pursuant to the Merger Agreement, these restricted shares were canceled and converted into the right to receive the Consideration.
- [F4]Represents the disposition of options, which provided for vesting in four equal installments beginning February 22, 2017. The options were cancelled pursuant to the Merger Agreement in exchange for a cash payment of $7.14 per share subject to the option. This per share price represents the difference between the applicable exercise price of the option and the Consideration.
- [F5]Represents the disposition of options, which provided for vesting in four equal installments beginning February 18, 2015. The options were cancelled pursuant to the Merger Agreement in exchange for a cash payment of $1.59 per share subject to the option. This per share price represents the difference between the applicable exercise price of the option and the Consideration.
- [F6]Represents the disposition of options, which provided for vesting in four equal installments beginning February 21, 2014. The options were cancelled pursuant to the Merger Agreement in exchange for a cash payment of $5.30 per share subject to the option. This per share price represents the difference between the applicable exercise price of the option and the Consideration.
- [F7]Represents the disposition of options, which provided for vesting in four equal installments beginning September 19, 2012. The options were cancelled pursuant to the Merger Agreement in exchange for a cash payment of $1.65 per share subject to the option. This per share price represents the difference between the applicable exercise price of the option and the Consideration.